FFFHX | RDITX | FFFHX / RDITX | |
Total Expense Ratio | 0.75 | 0.72 | 104% |
Annual Report Gross Expense Ratio | 0.75 | 0.72 | 104% |
Fund Existence | 19 years | 18 years | - |
Gain YTD | 5.113 | 6.715 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.3B | 36.5B | 53% |
Annual Yield % from dividends | 1.14 | 0.96 | 119% |
Returns for 1 year | 8.27 | 9.84 | 84% |
Returns for 3 years | 43.95 | 38.43 | 114% |
Returns for 5 years | 40.74 | 46.54 | 88% |
Returns for 10 years | 42.13 | 72.41 | 58% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 77.13 | -0.37 | -0.48% |
T. Rowe Price Health Sciences | |||
WLCIX | 14.32 | -0.11 | -0.76% |
Allspring Large Company Value Inst | |||
SEQAX | 16.76 | -0.19 | -1.12% |
NAA World Equity Income A | |||
FCBSX | 33.01 | -0.46 | -1.37% |
Franklin Mutual U.S. Mid Cap Value C | |||
LISIX | 15.55 | -0.23 | -1.46% |
Lazard International Strategic Eq Instl |